v3.22.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 1,808 $ 258
General and administrative 1,055 743
Loss from operations (2,863) (1,001)
Interest income (2) (3)
Net Loss $ (2,861) $ (998)
Net loss per common share outstanding, basic $ (0.14) $ (0.06)
Net loss per common share outstanding, diluted $ (0.14) $ (0.06)
Weighted average number of common shares outstanding, basic 20,957,181 16,556,320
Weighted average number of common shares outstanding, diluted 20,957,181 16,556,320

Source